John Eikelboom Google Scholar: h-index, Total Citations, and Citation Map
John Eikelboom 's h-index is 156 (736 i10-index, 231,581+ total citations across 1,000+ publications) according to Google Scholar as of October 2026. John Eikelboom is affiliated with Unknown affiliation.
John Eikelboom is a researcher affiliated with Unknown affiliation, specializing in various fields. Their work has been cited 231,581 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
John Eikelboom 's Citation Metrics
Bibliometric impact based on 1,000 indexed publications. Of these, 17 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 156
- i10-Index
- 736
- Total Citations
- 231,581
- Citing Countries
- 76
As of October 2026.
John Eikelboom has an h-index of 156 and 231,581 total citations across 1000 publications, with research cited by institutions in 76 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing John Eikelboom 's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
201768,610
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher produced a highly cited, authoritative annual report on heart disease and stroke statistics for the American Heart Association, establishing a critical benchmark for cardiovascular epidemiology.
The researcher established the clinical efficacy of combining clopidogrel with aspirin for acute coronary syndromes without ST-segment elevation, a finding that has profoundly influenced standard cardiovascular care protocols.
The researcher conducted a pivotal comparative study of dabigatran versus warfarin for atrial fibrillation, establishing a foundational benchmark in anticoagulation therapy.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About John Eikelboom 's research
John Eikelboom is a researcher at Unknown affiliation. Their work has been cited 231,581 times across 1,000 publications (h-index 156), according to Google Scholar.
Their most-cited work, “Heart disease and stroke statistics—2017 update: a report from the American Heart Association” (2017), has accumulated 68,610 citations. Other influential works include “Dabigatran versus Warfarin in Patients with Atrial Fibrillation” (2009) with 16,083 citations and “Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation” (2001) with 9,088 citations.
Citations of John Eikelboom 's research come primarily from United States, China and United Kingdom, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
